Diabetes mellitus and subsite-specific colorectal cancer risks in the Iowa Women's Health Study.
暂无分享,去创建一个
A. Folsom | D. Jacobs | K. Anderson | D. Lazovich | K. Nicodemus | P. Limburg | C. Hong | T. Johnson
[1] N. Cook,et al. Dietary glycemic load and risk of colorectal cancer in the Women's Health Study. , 2004, Journal of the National Cancer Institute.
[2] I. Sobhani,et al. Leptin reduces the development of the initial precancerous lesions induced by azoxymethane in the rat colonic mucosa. , 2004, Gastroenterology.
[3] W. Willett,et al. Comparison of risk factors for colon and rectal cancer , 2004, International journal of cancer.
[4] D. Silverman,et al. Cancer risk in patients with diabetes mellitus , 1991, Cancer Causes & Control.
[5] A. Jemal,et al. Cancer Statistics, 2004 , 2004, CA: a cancer journal for clinicians.
[6] E. Riboli,et al. Plasma insulin, IGF‐binding proteins‐1 and ‐2 and risk of colorectal cancer: A prospective study in Northern Sweden , 2003, International journal of cancer.
[7] S. Bell,et al. Low-Glycemic-Load Diets: Impact on Obesity and Chronic Diseases , 2003, Critical reviews in food science and nutrition.
[8] A. Miller,et al. Glycemic load, carbohydrate intake, and risk of colorectal cancer in women: a prospective cohort study. , 2003, Journal of the National Cancer Institute.
[9] J. Brand-Miller. Glycemic load and chronic disease. , 2003, Nutrition reviews.
[10] J. Cerhan,et al. Cigarette smoking and colorectal cancer: long-term, subsite-specific risks in a cohort study of postmenopausal women. , 2003, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[11] N. Rifai,et al. Association of markers of insulin and glucose control with subsequent colorectal cancer risk. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[12] J. Gerich. Contributions of insulin-resistance and insulin-secretory defects to the pathogenesis of type 2 diabetes mellitus. , 2003, Mayo Clinic proceedings.
[13] R. Henry. Insulin resistance: from predisposing factor to therapeutic target in type 2 diabetes. , 2003, Clinical therapeutics.
[14] A. Hokama,et al. Relationship Between Diabetes Mellitus and the Site of Colorectal Cancer , 2003, American Journal of Gastroenterology.
[15] W. R. Bruce,et al. Direct measure of insulin sensitivity with the hyperinsulinemic-euglycemic clamp and surrogate measures of insulin sensitivity with the oral glucose tolerance test: correlations with aberrant crypt foci promotion in rats. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[16] Edward Giovannucci,et al. Modifiable risk factors for colon cancer. , 2002, Gastroenterology clinics of North America.
[17] C. la Vecchia,et al. Diabetes mellitus, family history, and colorectal cancer , 2002, Journal of epidemiology and community health.
[18] Preventive-care practices among persons with diabetes--United States, 1995 and 2001. , 2002, MMWR. Morbidity and mortality weekly report.
[19] J. Fulton,et al. Subsite‐specific incidence rate and stage of disease in colorectal cancer by race, gender, and age group in the United States, 1992–1997 , 2001, Cancer.
[20] E. Giovannucci. Insulin, insulin-like growth factors and colon cancer: a review of the evidence. , 2001, The Journal of nutrition.
[21] I. Tomlinson,et al. Microsatellite instability and the clinicopathological features of sporadic colorectal cancer , 2001, Gut.
[22] E. Paskett,et al. Colorectal cancer screening in North Carolina: associations with diabetes mellitus and demographic and health characteristics. , 2001, Preventive medicine.
[23] L. Vatten,et al. Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI: exploring the hyperinsulinaemia hypothesis , 2001, British Journal of Cancer.
[24] A. Lindblom. Different mechanisms in the tumorigenesis of proximal and distal colon cancers , 2001, Current opinion in oncology.
[25] T. Rohan,et al. The relation of type 2 diabetes and cancer. , 2001, Diabetes technology & therapeutics.
[26] C. Russell,et al. Regulation of leptin production in humans. , 2000, The Journal of nutrition.
[27] E. Riboli,et al. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. , 2000, Journal of the National Cancer Institute.
[28] N. Calonge,et al. Validation of self-reported chronic conditions and health services in a managed care population. , 2000, American journal of preventive medicine.
[29] W. Willett,et al. A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[30] M. Stampfer,et al. A prospective study of plasma levels of insulin-like growth factor I (IGF-I) and IGF-binding protein-3, and colorectal cancer risk among men. , 2000, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.
[31] A. Renehan,et al. Response: More About: Prospective Study of Colorectal Cancer Risk in Men and Plasma Levels of Insulin-Like Growth Factor (IGF)-I and IGF- Binding Protein-3 , 1999 .
[32] L H Kuller,et al. Increased blood glucose and insulin, body size, and incident colorectal cancer. , 1999, Journal of the National Cancer Institute.
[33] S. Devesa,et al. Incidence of colorectal carcinoma in the U.S. , 1999, Cancer.
[34] G A Colditz,et al. Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. , 1999, Journal of the National Cancer Institute.
[35] Stampfer,et al. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. , 1999, Journal of the National Cancer Institute.
[36] E. Calle,et al. Colorectal cancer: another complication of diabetes mellitus? , 1998, American journal of epidemiology.
[37] A. Børresen-Dale,et al. Different genetic pathways to proximal and distal colorectal cancer influenced by sex‐related factors , 1997, International journal of cancer.
[38] C. la Vecchia,et al. Diabetes mellitus and colorectal cancer risk. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[39] L. Kolonel,et al. Associations of sedentary lifestyle, obesity, smoking, alcohol use, and diabetes with the risk of colorectal cancer. , 1997, Cancer research.
[40] J. Potter,et al. Dietary sugar and colon cancer. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[41] J. Girard,et al. Is leptin the link between obesity and insulin resistance? , 1997, Diabetes & metabolism.
[42] A. Green,et al. Cancer and diabetes ‐ a follow‐up study of two populationbased cohorts of diabetic patients , 1997, Journal of internal medicine.
[43] H. Adami,et al. Diabetes mellitus and risk of large bowel cancer. , 1997, Journal of the National Cancer Institute.
[44] T. Sellers,et al. Physical activity and mortality in postmenopausal women. , 1997, JAMA.
[45] A. Medline,et al. Insulin promotion of colon tumors in rats. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[46] M. Harris. Chapter 2 Classification , Diagnostic Criteria , and Screening for Diabetes , 1996 .
[47] K. Steenland,et al. Cancer incidence in the National Health and Nutrition Survey I. Follow-up data: diabetes, cholesterol, pulse and physical activity. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[48] G. McKeown-Eyssen. Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk? , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[49] T. Sellers,et al. Mortality and cancer rates in nonrespondents to a prospective study of older women: 5-year follow-up. , 1994, American journal of epidemiology.
[50] R. Hultcrantz,et al. Growth-regulatory effects of sensory neuropeptides, epidermal growth factor, insulin, and somatostatin on the non-transformed intestinal epithelial cell line IEC-6 and the colon cancer cell line HT 29. , 1993, Scandinavian journal of gastroenterology.
[51] M. Marmot,et al. Post-challenge glucose concentration, impaired glucose tolerance, diabetes, and cancer mortality in men. , 1992, American journal of epidemiology.
[52] K. Midthjell,et al. Is questionnaire information valid in the study of a chronic disease such as diabetes? The Nord-Trøndelag diabetes study. , 1992, Journal of epidemiology and community health.
[53] K. Anderson,et al. Serum cholesterol level, body mass index, and the risk of colon cancer. The framingham study , 1992, Cancer.
[54] J. Potter,et al. Increased incidence of carcinoma of the breast associated with abdominal adiposity in postmenopausal women. , 1990, American journal of epidemiology.
[55] T. Tsuruo,et al. Insulin and Insulin‐like Growth Factor 1 Stimulate Proliferation of Metastatic Variants of Colon Carcinoma 26 , 1989, Japanese journal of cancer research : Gann.
[56] A. Folsom,et al. Accuracy and reliability of self-measurement of body girths. , 1988, American journal of epidemiology.
[57] W. Willett,et al. The use of a self-administered questionnaire to assess diet four years in the past. , 1988, American journal of epidemiology.
[58] L. Melton,et al. Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus. , 1982, Journal of chronic diseases.
[59] A. Belanger,et al. The Framingham study. , 1976, British medical journal.
[60] I. I. Kessler. Cancer mortality among diabetics. , 1970, Journal of the National Cancer Institute.